Clinical Trial Update: Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [NA]

View source ↗

Summary

This entry reports a completed clinical trial evaluating cetuximab with gemcitabine and oxaliplatin in locally advanced or metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Miami | Conditions: Pancreatic Cancer | NA | Status: COMPLETED